Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SYK | P43405 | 6/20 | 0.49 |
| ▸ | EGFR | P00533 | 10/20 | 0.47 |
| ▸ | ITK | Q08881 | 8/20 | 0.47 |
| ▸ | CTSC | P53634 | 3/20 | 0.46 |
| ▸ | BTK | Q06187 | 1/20 | 0.45 |
| ▸ | ZAP70 | P43403 | 1/20 | 0.43 |
| ▸ | CAMK1D | Q8IU85 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL657554 | 0.90 | SYK (0.50) | SYKEGFRITK | |
| SCHEMBL3834043 | 0.88 | EGFR (0.62) | SYKEGFRITKBTK | |
| SCHEMBL656581 | 0.87 | EGFR (0.49) | SYKEGFRITKBTK | |
| SCHEMBL657968 | 0.86 | EGFR (0.50) | SYKEGFRITKBTK | |
| SCHEMBL657843 | 0.85 | SYK (0.40) | SYKEGFRITKBTK | |
| SCHEMBL656244 | 0.85 | EGFR (0.45) | SYKEGFRITKBTK | |
| SCHEMBL656118 | 0.83 | EGFR (0.47) | SYKEGFRITKBTK | |
| SCHEMBL657135 | 0.82 | SYK (0.53) | SYKEGFRITKBTK | |
| SCHEMBL3835798 | 0.82 | EGFR (0.42) | SYKEGFRITKBTK | |
| SCHEMBL3840173 | 0.80 | SYK (0.46) | SYKEGFRITK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2130541-A2 | Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds | Rigel Pharmaceuticals, Inc. (US) | 2009-12-09 | — | — | EP | claimed |